Povidone-Iodine for Endophthalmitis Prophylaxis

Endophthalmitis is an uncommon postprocedure complication with a reported incidence of 0.028% after cataract surgery, 0.011% after pars plana vitrectomy, and 0.108% after penetrating keratoplasty. The reported rate of endophthalmitis after intravitreal injection of anti–vascular endothelial growth factor (anti-VEGF) agents is 0.02%. Although endophthalmitis is an infrequent complication, it often portends a very poor visual prognosis.

The most common sources of ocular pathogen contamination include the conjunctiva and eyelids. The goal of preprocedure antisepsis is to reduce the ocular surface pathogen load but not alter the bacterial flora in a manner leading to antimicrobial resistance or the presence of more virulent organisms. In the current issue of American Journal of Ophthalmology , Hsu and associates report a study of conjunctiva floral cultures and their antimicrobial resistance patterns in patients treated with anti-VEGF intravitreal injections for age-related macular degeneration. In this study, the intravitreal injection procedure included preprocedure application of povidone-iodine but no use of topical antibiotics. The authors conclude that the antibiotic susceptibility and growth patterns remain unaltered when using povidone-iodine prophylaxis alone (without topical antibiotics) for repeated monthly intravitreal injections. However, the study is limited by a small sample size, relatively short follow-up, and lack of a control group.

Povidone-iodine, an iodophor containing a loose combination of iodine with a nonionic surfactant in which some of the iodine may be available in its molecular form, is a potent antiseptic with a wide spectrum of activity against both gram-positive and gram-negative bacteria, fungi, and viruses. Preoperative antisepsis with povidone-iodine has been reported to reduce bacterial colony counts on the ocular surface. Allergies to seafood as well as iodinated contrast media are not contraindications to povidone-iodine. There is general consensus to use povidone-iodine as prophylaxis for endophthalmitis, but variations exist in practice patterns and recommendations regarding usage of povidone-iodine in preventing postprocedure endophthalmitis.

Preoperative preparation of the skin and periocular area is typically performed using 10% povidone-iodine. This preparation minimizes transfer of bacteria from the periocular skin and eyelids into the eye. A study comparing different concentrations of povidone-iodine for skin preparation found that use of 5% povidone-iodine was associated with an 11-fold greater odds of acute post–cataract surgery endophthalmitis compared with 10% povidone-iodine, when both were combined with conjunctival 5% povidone-iodine instillation. Dilute povidone-iodine has a smaller iodine reservoir compared to more concentrated povidone-iodine; therefore, dilute povidone-iodine may become saturated and depleted upon tissue contact. Conversely, 10% povidone-iodine has a greater iodine reservoir and more efficacious antiseptic effect when used for preoperative skin preparation.

The American Academy of Ophthalmology “Cataract in the Adult Eye” Preferred Practice Patterns Guidelines recommend that topical 5% povidone-iodine drops be instilled into the conjunctival cul de sac preoperatively, whereas the Royal College of Ophthalmology Cataract Surgery Guidelines recommend a flush irrigation of 5% povidone-iodine into the conjunctival sac. De Kaspar and associates compared the effect of instillation of two 5% povidone-iodine drops vs 10 mL conjunctival irrigation of 5% povidone-iodine, and found that conjunctival irrigation was associated with fewer positive conjunctival cultures. It has been hypothesized that irrigation can reach the conjunctival crypts, especially those located in the fornices, which is not possible with topical drops alone. Conjunctival exposure to 5% povidone-iodine for a period of 30 seconds achieves a significant reduction in the bacterial colony-forming units and appears to be an adequate contact time before intravitreal injection.

Topical antibiotic use for prophylaxis of endophthalmitis following intravitreal injection is not the current standard of care owing to emerging antimicrobial resistance and failure to reduce endophthalmitis rates. Experimental studies have shown that microbial strains that acquired resistance against one antiseptic agent also showed cross-resistance to other antiseptics, such as chlorhexidine gluconate and alkyldiaminoethylglycine hydrochloride, but not to povidone-iodine. Furthermore, a study was conducted in the 1970s to determine whether bacterial resistance to povidone-iodine could be induced in vitro using strains of pathogenic bacteria. The study found that even after repeated exposure to povidone-iodine and with 20 serial passages, no significant change was observed in the minimal inhibitory concentration, minimal bactericidal concentration, and killing times between parent strains and 20th subcultures under standardized conditions. Considering that iodine-containing antiseptic agents have been in use for more than a century, it is likely that the mechanism of action of povidone-iodine is not associated with the development of antimicrobial resistance.

In conclusion, compared to topical antibiotics, prophylaxis with povidone-iodine is the most effective and least expensive method to prevent postprocedure endophthalmitis, and it has not been associated with the development of antimicrobial resistance or the presence of more virulent species of bacteria.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jan 8, 2017 | Posted by in OPHTHALMOLOGY | Comments Off on Povidone-Iodine for Endophthalmitis Prophylaxis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access